What is Bonum Therapeutics worth?
$130.0Mlast known valuation
Bonum Therapeutics last raised $26.9M in its Early Stage VC (Apr 2026).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Bonum Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2026 | Early Stage VC | $26.9M | ▮ | ▮ |
| Nov 2022 | Early Stage VC | $45.0M | ▮ | ▮ |
| Dec 2021 | Seed Round | $1.2M | ▮ | ▮ |
How Bonum Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Bonum Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Bonum Therapeutics worth?
- Bonum Therapeutics's last known valuation is $130.0M.
- How much has Bonum Therapeutics raised?
- Bonum Therapeutics has raised $127.5M in total funding across 3 recorded rounds.
- When did Bonum Therapeutics last raise?
- Bonum Therapeutics last raised in Apr 2026 (Early Stage VC), raising $26.9M.